Sara Redd
Media Expertise:
Health policy, maternal and child health, reproductive health, sexual health/behavior, social determinants of health, women's health
Contact Rob Spahr, Director of Public Relations, to request an interview:
rob.spahr@emory.edu
Bio
Sara K. Redd, PhD, MSPH is a Georgia native, an Assistant Professor in the Department of Behavioral, Social, and Health Education Sciences (BSHES), and the Director of Research Translation with the Center for Reproductive Health Research in the Southeast (RISE) at the Rollins School of Public Health at Emory University. Trained in health policy, health services research, and social science, Dr. Redd is an interdisciplinary scholar of sexual and reproductive health (SRH) in the United States. More specifically, Dr. Redd studies domestic sexual and reproductive health (SRH) policy, structural determinants of access to and use of comprehensive SRH care and downstream health outcomes, and multilevel SRH stigma and mis/disinformation. Informed by the Reproductive Justice framework, Dr. Redd examines and highlights how sociopolitical systems and structures enforce or ameliorate inequities in SRH access and outcomes, paying special attention to those living in the South. Additionally, Dr. Redd is privileged to collaborate closely with several local and national reproductive health, rights, and justice organizations to support and conduct community-led and community-driven SRH research.
Areas of Interest
- Health Policy
- Health Promotion
- Maternal and Child Health
- Sexual Health/Behavior
- Advocacy
- Health Services Research
- Public Health Policy
- Reproductive Health
- Women’s Health
- Health Law
- Social Determinants of Health
Education
- PhD, Emory University
- MSPH, Emory University
- BA, Bucknell University
In The News
Ask an Expert: The U.S. Abortion Landscape and Policy with Sara Redd
Sara Redd, PhD, director of research translation with the Center for Reproductive Health Research in the Southeast, walks us through what happened and what this means in the context of the current abortion landscape in the U.S.
Reproductive Reality
Experts Offer Vital Insights on Mifepristone Safety, Efficacy, and Access
On March 26, the U.S. Supreme Court will hear oral arguments in a case that could limit access to mifepristone, a drug primarily used in medication abortion. Researchers from the Center for Reproductive Health Research in the Southeast weigh in on the state of mifepristone access, the potential implications of this case, and what the public needs to know.